146 related articles for article (PubMed ID: 30364030)
1. Knowledge and Attitudes of Saudi Emergency Physicians toward t-PA Use in Stroke.
Al Khathaami AM; Aloraini H; Almudlej S; Al Issa H; Elshammaa N; Alsolamy S
Neurol Res Int; 2018; 2018():3050278. PubMed ID: 30364030
[TBL] [Abstract][Full Text] [Related]
2. Stroke intervention and pharmacotherapy guidelines: Knowledge-to-practice translation gaps among the emergency resident physicians in Riyadh, Saudi Arabia.
Mohammed Algarni R; Albarrak MM; Alomaysh AM; Morsi AA; Lin C; Saad Almowalad E; Bahr MH
J Clin Neurosci; 2023 Apr; 110():109-115. PubMed ID: 36863126
[TBL] [Abstract][Full Text] [Related]
3. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke.
Brown DL; Barsan WG; Lisabeth LD; Gallery ME; Morgenstern LB
Ann Emerg Med; 2005 Jul; 46(1):56-60. PubMed ID: 15988427
[TBL] [Abstract][Full Text] [Related]
4. Views of emergency physicians on thrombolysis for acute ischemic stroke.
Bobrow BJ; Demaerschalk BM; Wood JP; Villarin A; Clark L; Jennings A
J Brain Dis; 2009; 1():29-37. PubMed ID: 23818807
[TBL] [Abstract][Full Text] [Related]
5. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia.
Al Khathaami AM; Al Bdah B; Tarawneh M; Alskaini M; Alotaibi F; Alshalan A; Almuhraj M; Aldaham D; Alotaibi N
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225
[TBL] [Abstract][Full Text] [Related]
6. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
Ingall TJ; O'Fallon WM; Asplund K; Goldfrank LR; Hertzberg VS; Louis TA; Christianson TJ
Stroke; 2004 Oct; 35(10):2418-24. PubMed ID: 15345796
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with late arrival of acute stroke patients to emergency department in Saudi Arabia.
Al Khathaami AM; Mohammad YO; Alibrahim FS; Jradi HA
SAGE Open Med; 2018; 6():2050312118776719. PubMed ID: 29844910
[TBL] [Abstract][Full Text] [Related]
8. Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals.
Scott PA; Xu Z; Meurer WJ; Frederiksen SM; Haan MN; Westfall MW; Kothari SU; Morgenstern LB; Kalbfleisch JD
Stroke; 2010 Sep; 41(9):2026-32. PubMed ID: 20705931
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the experience of Saudi emergency medical services personnel with acute stroke. On-scene stroke identification, triaging, and dispatch of acute stroke patients.
Althubaity E; Yunus F; Al Khathaami AM
Neurosciences (Riyadh); 2013 Jan; 18(1):40-5. PubMed ID: 23291796
[TBL] [Abstract][Full Text] [Related]
10. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
[TBL] [Abstract][Full Text] [Related]
11. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.
; Levine SR; Khatri P; Broderick JP; Grotta JC; Kasner SE; Kim D; Meyer BC; Panagos P; Romano J; Scott P;
Stroke; 2013 Sep; 44(9):2500-5. PubMed ID: 23847249
[TBL] [Abstract][Full Text] [Related]
12. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
[TBL] [Abstract][Full Text] [Related]
13. Virtual TeleStroke support for the emergency department evaluation of acute stroke.
Schwamm LH; Rosenthal ES; Hirshberg A; Schaefer PW; Little EA; Kvedar JC; Petkovska I; Koroshetz WJ; Levine SR
Acad Emerg Med; 2004 Nov; 11(11):1193-7. PubMed ID: 15528584
[TBL] [Abstract][Full Text] [Related]
14. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
15. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
16. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
Stroke; 1997 Aug; 28(8):1530-40. PubMed ID: 9259745
[TBL] [Abstract][Full Text] [Related]
17. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke.
Bourekas EC; Slivka AP; Shah R; Sunshine J; Suarez JI
Neurosurgery; 2004 Jan; 54(1):39-44; discussion 44-6. PubMed ID: 14683539
[TBL] [Abstract][Full Text] [Related]
18. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
[TBL] [Abstract][Full Text] [Related]
19. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
20. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
